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Abstract 
Background: Molecularly imprinted polymer (MIP) technique is a powerful mean to produce tailor made synthetic 
recognition sites. Here precipitation polymerization was exploited to produce a library of MIP nanoparticles (NPs) 
targeting the N terminus of the hormone Hepcidin-25, whose serum levels correlate with iron dis-metabolisms and 
doping. Biotinylated MIP NPs were immobilized to NeutrAvidin™ SPR sensor chip. The response of the MIP NP sensor 
to Hepcidin-25 was studied.
Findings: Morphological analysis showed MIP NPs of 20–50 nm; MIP NP exhibited high affinity and selectivity for the 
target analyte: low nanomolar Kds for the interaction NP/Hepcidin-25, but none for the NP/non regulative Hepci-
din-20. The MIP NP were integrated as recognition element in SPR allowing the detection of Hepcidin-25 in 3 min. 
Linearity was observed with the logarithm of Hepcidin-25 concentration in the range 7.2–720 pM. LOD was 5 pM. The 
response for Hepcidin-20 was limited. Hepcidin-25 determination in real serum samples spiked with known analyte 
concentrations was also attempted.
Conclusion: The integration of MIP NP to SPR allowed the determination of Hepcidin-25 at picomolar concentrations 
in short times outperforming the actual state of art. Optimization is still needed for real sample measurements in view 
of future clinical applications.
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Background
The analytical determination of a target molecule is 
dependent on its specific interaction with a recogni-
tion element [1, 2]. Thus in sensing technologies, both 
knowledge on the intermolecular interactions and the 
ability to control over the recognition processes are keys 
to improve and enhance the sensitivity and the selectiv-
ity of the system [3, 4]. Aiming at increasing the sensor 
performance significant efforts are put on the improve-
ment of the recognition element. Biological recogni-
tion, principally actuated by antibodies and receptors, is 
known to offer exquisite specificity and selectivity, while 
often lacking of long term stability, since proteinaceous 
material exhibits the tendency to unfold when coupled 
to the transducer. Thus synthetic recognition elements 
are gaining increasing importance in the field [3, 5]. 
Among the methods for their preparation, the molecu-
lar imprinting of polymers (MIP) is a versatile technol-
ogy for imparting entailed recognition properties to 
polymeric materials [6–8]. The concept was established 
in 1972 by Wulff and Sarhan, when they investigated a 
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new method to introduce functional groups with speci-
fied stereochemical properties into polymers [9]. Briefly 
MIPs are produced via a template assisted synthesis: 
(1) the target analyte, called the template, is solvated 
together with selected functional monomers, these latter 
re-organize around the template in a thermodynamically 
driven process that lead to the minimum configuration 
energy and to the formation of template-monomers pre-
polymerization complexes (2) with the addition of the 
crosslinker and the initiators the material is polymerized, 
(3) at the end of the synthesis, unreacted monomers and 
the template are removed by washings, leaving a polymer 
with molecular cavities complementary to the template 
exposed and prone for rebinding.
Inherent advantages of MIPs are the stability of the 
polymeric material to harsh conditions, the cheap syn-
thesis, the processability, the ease of integration to sen-
sors and the great flexibility of the imprinting strategy, 
which allows in principle to prepare binding materials for 
whatsoever target analyte (from small molecules to pro-
teins, to bacteria and viruses and to impart the desired 
degree of affinity [10, 11]. MIP selectivities and affini-
ties have been reported on the par of natural antibodies 
[12, 13]. For all these reasons the exploitation of MIPs as 
mimic of the biological recognition element is well con-
solidated in analytical technologies [i.e. chromatogra-
phy, capillary electrophoresis (CE)] [14], assays [12] and 
sensors [10, 15–17]. So far, the majority of the reported 
MIPs have been imprinted in organics and the majority 
of the targets are small analytes, while the current state of 
the art addresses the issues of imprinting complex mol-
ecules aqueous solvated, such as proteins, hormones and 
signal peptides, for whose water compatible MIPs are 
under development [18–20]. A further frontier research 
area focus on the structural architecture of the MIP poly-
mer which is rapidly evolving from the more traditional 
macropolymeric bulk material, to micro and nanostruc-
tures [21]. Undoubtedly, MIP macrostructures have been 
offering high loading capacity which is of advantage for 
their incorporation into a sensor. At the same time the 
physical limitations inherent with the macrodimensions 
often brought the sensing process to only partial success. 
Specific limitations associated with the macrodimensions 
are the inhomogeneity of the macroparticulate, which 
results in lack of uniformity of the polymer fragments 
and non consistency of the quantity of available binding 
sites per polymer macroparticle; these affect both the 
time of response of the sensor (i.e. the equilibrium time 
is not constant; the signal stabilization could require 
hours) and the reproducibility of the response. Moreover 
the MIP macroparticulate exhibited scarce compatibility 
with some transduction forms, such as surface plasmon 
resonance (SPR) detection. In SPR the binding event 
shall occur within a depth of 200 nm from the metal sur-
face, i.e. a distance within which the analyte-receptor 
interaction effectively perturbs the plasmonic wave and 
generates a detectable signal, yet such distance is rather 
incompatible with macrostructured MIPs [22].
Nowadays nanometric sized objects have been demon-
strated to posses unique molecular, physical and chemi-
cal properties [23]: increased surface to volume ratio, 
less defects in the material, i.e. monodispersity of the 
nanoparticle (NP) population, homogeneity of the bind-
ing sites, equivalent number of binding sites per NP, 
higher accessibility of the binding sites, distinctive opti-
cal properties, i.e. discrete light absorbtion or emission, 
badgap etc. [23] are among the key features of nanoma-
terials, which have been allowing the development of a 
new generation of sensors with superior performances 
respect to the former macro-material-based [3, 4, 24]. In 
case of MIPs, nanoMIPs have been outperforming mac-
roMIPs sensitivity and detection limits of at least three 
orders of magnitude [22, 25, 26], thus nanometric sized 
MIPs are being pursued. Protocols for downsizing MIPs 
to NPs or nanofilms are foreseen as strategic for the suc-
cess of MIP-sensing [9] with important impact on real 
time monitoring [11].
Nano-MIPs are reported in the form of nanosurfaces, 
i.e. thin films, or NPs [9, 27, 28]. These can be produced 
either by blending MIPs into supporting or sacrificial 
nanostructured materials [29], or by core–shell synthe-
sis over polymeric or inorganic nanostructures, such 
as quantum dots, silica or metallic NPs [30, 31], or by 
synthesizing whole polymeric MIP NPs [32, 33]. In the 
present account, entirely polymeric MIP NPs, prepared 
through a precipitation polymerization protocol [32], 
were studied. These were selected for their favorable 
characteristics of high yield, water compatibility, small 
dimensions (10–100  nm), which suit well our goals to 
target a peptide biomarker and to be integrated into a 
SPR sensor in similarity with antibodies.
Target analyte for this study was the peptide hormone 
Hepcidin-25 which plays a key role in iron homeosta-
sis, being the only regulator of the iron efflux from stor-
age cells, i.e. macrophages and hepatocytes, to serum 
[34–37]. The mature form of the hormone, Hepcidin-25, 
is a biomarker for iron dis-metabolisms, inflammations 
and doping [27, 38]; its determination in serum helps in 
the clinical assessment of the different iron metabolism 
disorders, offering indications for the prognosis and 
therapeutic interventions [39–44]. Moreover, the tight 
link between iron metabolism and erythropoietic activ-
ity correlates Hepcidin-25 levels to blood doping in ath-
letes [38]. Whereas the circulating truncated forms of 
the hormone, i.e. Hepcidin-24, 22 and 20, progressively 
lacking of portions of the N terminus, appear not to be 
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involved in the iron regulation and still have unknown 
roles [45–47].
Despite the interests for the quantitative determina-
tion of Hepcidin-25, the structural characteristics of this 
hormone hampered its detection for quite a long time. In 
particular, Hepcidin-25 has a rigid structure kept in place 
by four disulphide bridges [48, 49], small dimensions 
(2789 Da) and a high degree of conservation through the 
evolutive scale, characteristics that hampered the pro-
duction of antibodies up to very recent years [50, 51]. 
Methods based on mass spectrometry (MS) were pro-
posed as an alternative [39, 52–54]. Nevertheless the 
quantitative determination of Hepcidin-25 is still an open 
issue, as resulted by round-robin studies that compared 
the actual hepcidin quantification methods [55].
The MIP strategy for Hepcidin-25 determination was 
also attempted in 2010 [56]. In the case, MIP hydrogels of 
about 100 micrometer in size were prepared in aqueous 
solution and targeted the N terminus peptide of Hepci-
din. Results indicated that the microMIP had an imprint-
ing factor (IFs) of about 1.1–1.5 with an incubation 
times of about 24  h [56]. As a consequence the micro-
MIP material was rather inconvenient both for sensing 
and for clinical assays. In the present study, we aimed 
at optimizing the MIP composition for the recognition 
of Hepcidin-25, to miniaturize the MIP to nanomaterial 
for its further integration into an optical sensor for the 
real time monitoring of the hormone. We thus prove the 
possibility to imprint polymeric NPs with the N-terminus 
portion of the hormone, with the goal to produce easy 
to synthesize and selective recognition elements able to 
discriminate the bioactive full length Hepcidin-25 from 
truncated hepcidin. As shown in Fig.  1, the MIP NPs 
were integrated into optical SPR sensor and the perfor-
mance of the sensor was evaluated in model solutions, 
proving the possibility to detect the hormone at picomo-
lar levels.
Results and discussion
Rational design, synthesis and physical characterization 
of MIP NPs
The selection of the template was based on the epitope 
imprinting strategy [57–59]. The N-terminus hexapep-
tide of Hepcidin-25, with sequence DTHFPI, was there-
fore designated as template both for its putative role in 
triggering the iron-regulation response [60], and for the 
short and linear sequence, which can be imprinted with 
higher fidelity respect to the full hormone, that retain 
a hairpin secondary structure [57]. The same template 
selection was adopted earlier by Abbate [56]. Consider-
ing the peptidic nature of the template and its amphi-
pathic character, we aimed at preparing an aqueous 
compatible polymer composed of a variety of mono-
mers, i.e. neutral, hydrophobic and charged, in order to 
match all the different functionalities of the aminoacids 
with complementary weak interactions: hydrogen bonds, 
hydrophobic, electrostatic. This was achieved with the 
combination of: acrylamide (Aam), tert-butylacrylamide 
(TBAm), diethyl aminoethyl methacrylate (DEAEm) and 
methacrylic acid (MAA) monomers, as successfully indi-
cated by Hoshino [32]. Bisacrylamide was the crosslinker. 
Differently from the work published by Shea’s group [32], 
we decided to use the 80 % w/v of crosslinker, to confer 
and maintain a certain degree of rigidity in the polymer, 
in fact in previous attempts with lowly crosslinked mac-
rostructures (<5  % C) we encountered the problem of 
Fig. 1 Scheme of MIP NP SPR sensor. The MIP NPs anchored onto the chip surface through the biotin-NeutrAvidin™ bond are represented as red 
dots, the inset shows the MIP synthesis
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over-rehydration of the hydrogel [61], which at a molecu-
lar level results in a deformation of the recognition cavi-
ties or in less accessibility of the binding sites. Moreover 
the crosslinking level was similar to previous submicron 
sized hydrogels, mimic of biomolecules inhibitors, that 
have been reported to have exquisite interaction with the 
active site of enzymes [33].
The MIP selection of the charged monomers was done 
with the aid of molecular modelling [13]. Here, the N ter-
minus of Hepcidin-25 was docked with a combination of 
charged (either DEAEm or MAA) and neutral monomers 
(Aam): to mimic the pre-polymerization solution two 
monomers of a same charge and two neutral monomers 
were funneled through the HADDOCK software. At the 
end of the simulation the HADDOCK score values, that 
indicate the strength of the complex, showed a stronger 
interaction for MAA/template (−68.0 a.u.) respect to 
DEAEM/template (−59.2 a.u.), thus MAA was used for 
the syntheses (details in Additional file 1).
The synthesis of the NPs was conducted with a total 
monomer concentrations of 14 or 35 mM, in water sup-
plemented with 0.02 %, SDS [32] and triggered with the 
chemical free-radical-generating pair TEMED/APS, for 
17 h in order to let the process reach the completion [32]. 
Respectively for 14 and 35 mM total monomers, the initi-
ator was the 3.5 % and the 7 % of the whole polymerizable 
double bonds in the solution. Such ratio, slightly higher 
than that used for the preparation of hydrogels (ca. 1.5 % 
initiator vs. mol of polymerizable double bonds) balanced 
the necessity to produce porous nanomaterial compat-
ible with the a fast equilibration of the peptide Hepcidin 
with the genesis of many nucleation centers elongating 
for shorter lengths, which should result in NPs <100 nm.
Different template concentrations (32 and 200  µM) 
were tested in the synthesis in order to assess the influ-
ence of the template vs. functional monomers ratio 
(mol:mol) over the MIP NP recognition properties (poly-
meric compositions in Additional file  2). Control, non 
imprinted, polymers, NIP NPs, were prepared in an iden-
tical manner but in the absence of template. The calcu-
lated yield for the synthesis was >90 %.
The physical characterization of the NPs was performed 
with Dynamic Light Scattering (DLS), Atomic Force 
Microscopy (AFM) and Scanning Electron Microscopy 
(SEM). DLS data are reported in Table 1, while the mor-
phological information of the NPs are shown in Fig. 2.
Table  1 reports the physical properties for each NP 
composition polymerized (NIP, MIP with 32  µM tem-
plate, MIP with 200 µM template, at 0.2 % T and at 0.5 % 
T). In general, the low polydispersity indexes measured 
(PDIs <0.3), indicated that uniform populations of NPs 
were synthesized by the precipitation polymerization 
method. As an exception, the MIP recipe 0.2 % T-32 µM 
template resulted in a higher inhomogeneity of the nano-
material (PDI 0.4).
The size distributions of the NPs ranged from 26 ± 0.1 
to 36 ±  0.3 nm for the syntheses conducted at 0.2 % T, 
while dimensions between 55 ± 0.1 and 69 ± 1 nm were 
observed for the syntheses conducted at 0.5  % T (see 
Table  1). A positive correlation between the particle 
dimension and the quantity of monomers in the synthesis 
protocol (% T) was observed. The same trend was seen 
for the estimated mean molecular weights (Mn) and % T: 
the 0.2  % T NPs were of about 700–1000  kDa, whereas 
the 0.5 % T NPs were of about 3500 kDa.
The dimension of the NPs was independently evalu-
ated by electron microscopy measurements (SEM Fig. 2a, 
b; AFM, Fig.  2c, d): the average diameters of the NPs 
resulted of ca. 27.4 ±  8.7 nm (Fig.  2d); qualitatively the 
NPs population appeared to include both single particles 
and small aggregates. DLS data were in agreement the 
electron microscopy measurements, despite the differ-
ent rehydration state of the NPs in the two analyses could 
explain small differences (DLS measures rehydrated NPs 
and over-estimate the size, AFM and SEM measure in 
dry state where the NPs shrunk).
The differences reported for the NPs prepared at 0.2 and 
0.5  % T (both MIP and NIP) were not substantial, thus 
to our judgement the best protocol was 0.5  % T, which 
ensured a higher quantity of NPs production per synthesis 
batch. Overall the results indicated that the NP character-
istics were comparable to those of large protein complexes. 
Table 1 Physical properties of the NPs
Total monomer  
concentration (%)
Template  
concentration (µM)
Size (nm) Mn (kDa) PDI Zeta potential 
(mV)
0.2 – 29 ± 0.3 1000 0.3 −10 ± 1
32 36 ± 1 1100 0.4 −12 ± 1
200 26 ± 0.1 700 0.3 −10 ± 1
0.5 – 55 ± 0.1 2600 0.2 −15 ± 1
32 52 ± 2 3500 0.2 −12 ± 1
200 69 ± 1 3400 0.2 −13 ± 1
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This is reported to give advantages in terms of fast bind-
ing equilibria, compatibility with fluidic system (no clog-
ging of tubings) [24], compatibility with protein handling 
protocols and limited number of binding sites per particle 
[62]. Therefore the synthesized MIP-NPs were compatible 
in dimension with the final goal of sensor integration.
Investigation over the MIP NPs recognition properties
The MIP NPs were then tested for their recognition 
properties towards their putative ligands by the iso-
thermal titration calorimetry (ITC) technique. The ITC 
method measures the heat exchanges associated with 
the formation of a complex, offering thermodynamic 
insights into the analyte/NP association. Here 1.2  µM 
of NP (MIP or NIP, called titrand) were titrated in 12 
sequential injections of a 4  µM solution of injectant 
(i.e. the hexapeptide template, or Hepcidin-25, or Hep-
cidin-20, or a non related peptide of 10 aminoacids 
(NR10), or a scramble sequence of the template). The 
heat generated upon each injection was recorded, inte-
grated and corrected by the subtraction of the heat of 
dilution contribution (i.e. injectant titrated into pure 
buffer). Corrected heat areas expressed in kJ/mol were 
plotted versus the molar ratio titrand/injectant and fit-
ted with a single point equation (see Additional file 3 for 
details).
Fig. 2 Morphological analysis of the MIP NPs. SEM (a, b) and AFM (c, d) analysis gave morphological information on the MIP NPs. SEM images indi-
cated a mean size of 55 ± 7 nm. The AFM measured a mean size of 27.4 ± 8.7 nm for the nanoparticles (d the length distribution in nm of five NPs 
was: #1 34.3; #2 25.2; #3 22.6; #3 20.5; #4 41.7; #5 20.1). The MIP NPs deposition indicates the presence of both single nanoparticle (ca. 22 nm) and 
small aggregates of dimensions <100 nm. The data are in agreement with the results of the DLS analysis
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The resulting thermodynamic data are reported in 
Table 2. All the binding events exhibited a negative ΔG°. 
The library of MIP NPs did bind the template hexapep-
tide with very low nanomolar dissociation constants 
(3–7  nM), indicating the high affinity of the MIP NP/
template interaction. The stoichiometry of the complex 
(n, Table 2) showed an interaction of about 1 mol of pep-
tide and 0.5 mol of MIP NP, result that, given the polydis-
persity of the NPs and the possibility to form aggregates 
in solution, can suggest a low number of high affinity 
binding sites per MIP NP, in analogy with other MIP NPs 
[62, 63]. An estimation of the binding capacity of the MIP 
NPs was attempted from the parameter n and resulted in 
ca. 2 µg/mg of MIP NPs.
The MIP NPs did bind full length Hepcidin-25 with a 
Kd of 13 nM. The affinity, the stoichiometry and the exo-
thermic effect for the binding of MIP NPs/Hepcidin-25 
were comparable to that of the binding MIP NP/hexapep-
tide and were indicative of the successful recognition of 
the template by the imprinting cavities, also when the N 
terminus hexapeptide is part of a structured polypeptide, 
such as the folded Hepcidin-25. These data corroborate 
and support the validity of the epitope strategy [57–59]. 
Moreover no binding was observed when MIP NPs were 
challenged with the truncated Hepcidin-20, lacking 
of the N terminus. This accounted for the selectivity of 
the MIP NPs and fully supported our initial hypothesis 
of targeting the N terminus of the hormone in view of 
developing an analytical system for the discrimination of 
the iron regulating form.
The selectivity of the MIP NPs was further confirmed 
in a titration experiment with a peptide having an unre-
lated peptide sequence (i.e. NR10): no interaction was 
measured. On the contrary, when the scramble hexapep-
tide sequence was tested for its recognition by the MIP 
NPs a high affinity was measured (despite a slightly less 
favourable energy was implicated). A possible explana-
tion implies that the recognition mechanism is mainly 
driven by the steric hindrance and by the surface charge 
density of the peptide, instead of relying on a strict 
sequence specificity.
All the controls performed titrating the NIP NPs with 
the template indicated no measurable binding. This was 
indeed another evidence of the efficacy of the imprint-
ing process to generate specific binding sites. Thus, we 
investigated further the genesis of the recognition sites 
on the NPs during the imprinting process, setting up an 
experiment in which the template was titrated to each 
MIP NPs of our library, i.e. made with: (1) different quan-
tities of template (32 or 200  µM) and (2) different total 
monomers concentration during the polymerization 
batches (0.2 and 0.5  % T), which corresponded respec-
tively to the following template:monomer molar ratio 
1:88; 1:222; 1:14; 1:35. As shown in Table 2, no significant 
changes or trends were evidenced by the thermodynamic 
parameters within the NP library. It could be hypoth-
esized that the formation of the imprinted cavities during 
the precipitation polymerization is not merely controlled 
by the quantity of monomers vs. template present in the 
polymerization solution. This raise new questions for 
the imprinting community about the rationalization and 
control over the MIP NPs synthesis. Few observations on 
the role exerted by the monomer composition in the rec-
ognition have been proposed in the recent past [64–66] 
and might fit to answer the here proposed question.
To summarize the functional data: overall the MIP NPs 
exhibited low nanomolar dissociation constants for their 
template and for Hepcidin-25, indicating exquisite rec-
ognition abilities on the par of monoclonal antibodies, 
and attuned selectivities that allows the discrimination 
of the active form of the hormone. These characteristics 
were considered appropriate for exploiting the behaviour 
of our MIP NPs in sensing. Moreover the MIP NPs lyo-
philized and stored at 4 °C did retain their binding prop-
erties form >6 months, confirming the stability of these 
synthetic recognition elements and accounting for their 
potential impact in substituting biomolecules in sensors.
Preparation of the MIP NP SPR sensor
The MIP NPs have been used earlier as synthetic rec-
ognition element in a surface plasmon resonance (SPR) 
Table 2 Thermodynamic constants for  the binding of  MIP 
NPs to different analytes measured by Isothermal Titration 
Calorimetry (ITC)
Experiments were performed by titrating 1.2 µM NPs with 4 µM ligand: 
dissociation constant (Kd), binding stoichiometry (n), enthalpy and Gibbs free 
energy variation. The heat contribution of control NPs was subtracted from MIP 
NPs, thus the resulting interactions are primarily driven by specific binding sites. 
Thermograms in Additional file 1
NP Ligand Kd (nM) n ΔH (kJ/
mol)
ΔG (kJ/
mol)
02 MIP32 DTHFPI 6 ± 3 0.4 ± 0.1 −261 ± 18 −47 ± 2
02 MIP200 DTHFPI 7 ± 1 0.4 ± 0.1 −128 ± 25 −46 ± 1
05 MIP32 DTHFPI 3 ± 1 0.4 ± 0.1 −177 ± 14 −49 ± 1
05 MIP200 DTHFPI 5 ± 3 0.5 ± 0.1 −131 ± 4 −48 ± 2
05 MIP200 Hepci-
din-25
13 ± 2 0.3 ± 0.1 −463 ± 46 −51 ± 9
05 MIP200 Hepci-
din-20
– – – –
05 MIP200 THFDPI 19 ± 5 0.5 ± 0.1 −395 ± 27 −37 ± 2
05 MIP200 NR10 – – – –
02 NIP DTHFPI – – – –
05 NIP DTHFPI – – – –
05 NIP Hepci-
din-25
– – – –
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microfluidic sensor [9, 67]. Here, the chosen surface suit-
able for the MIP NPs immobilization was the commercially 
available gold chip coated with NeutrAvidin™ (BioCap). At 
first the MIP NPs were derivatized with biotin-PEG-amine 
in order to introduce both the binding functionality and a 
spacer arm of 8 residues to prevent the steric hindrance of 
the particle at the chip surface (derivatization protocol and 
control experiments in Additional file  4). The size distri-
bution of control and biotinylated NPs was determined by 
DLS: MIP NPs showed a hydrodynamic diameter of 52 nm 
(±2) and a PDI of 0.2, while biotinylated MIP NPs had a 
diameter of 139  nm (±2) with a PDI of 0.3 (Additional 
file 4: Figures 4.1 and 4.2).
Then the MIP NPs were dispersed in HBS to a final 
concentration of 1 mg/ml and bound off line to the Neu-
trAvidin™ chip. The derivatized chip surface was imaged 
with AFM, as reported in Fig. 3 panels a, b: the morphol-
ogy of the surface was compatible with a homogeneous 
derivatization and showed a surface roughness (deep-
ness) of about 15  nm. The z-axis value resulted smaller 
than what expected from the DLS, but in line with AFM 
and SEM data reported in Fig. 2. This could be explained 
by the softness and flexibility of the polymeric MIP NPs, 
that do shrink in the dry conditions used for the AFM 
imaging. The dips panel reported in Fig.  3c shows the 
changes in the reflection angle at the chip surface prior 
(black signal) and after (grey signal) the derivatization 
with MIP NPs. The dip shift at higher angles (shifts to the 
right: channel 1 from 65 to 65.3°, channel 2 from 65 to 
65.4° and channel 3 from 65.1 to 65.5°) occurs when the 
mass on the sensing surface increases and could also be 
interpreted as a slight increment in hydrophobicity of the 
surface, once modified with the polymeric NPs [68].
Sample injection time for the SPR measurements
The SPR gives direct and real-time measurements of 
the binding events occurring at the sensor surface. As 
observed in Fig. 4, when the analyte is injected, the sen-
sorgram shows three different phases: a steep increment 
in the association phase, a plateau when the equilibrium 
between association and dissociation is reached and 
the dissociation phase when the buffer flows. Here we 
Fig. 3 Morphology of the chip sensor surface modified with MIP NPs. The morphology of the chip after MIP NP derivatization was investigated with 
AFM. The surface appeared uniformly covered with MIP NPs. The dips panel shows the SPR minima of one of the three channels before (black signal) 
and after (grey signal) the derivatization of the chip surface with MIP NPs. Each dip shifts to the right (higher SPR angles) when the mass increases on 
the corresponding sensing surface
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aimed the determination of the level of bound analyte 
and to correlate it to the injected concentration. This is 
normally performed by measuring the binding at a fixed 
time of sample injection, once the equilibrium has been 
reached. Therefore, the optimal contact time between the 
analyte and the MIP NP surface was defined evaluating 
the sensor response to a solution at fixed concentration 
of Hepcidin-25 (140 pM) flowing on the MIP NP surface 
at a constant flow rate (30  µl/min) but by changing the 
injection volumes from 30 to 300  µl. This allowed the 
contact time between the analyte and the MIP NP sur-
face to vary from 1 to 10 min. As indicated in Fig. 4, the 
equilibrium, represented by the plateauing of the signal, 
was obtained for an injection volume of 90  µl (3  min). 
Three minutes was the analysis time chosen for all the 
next experiments. The key advantage of the 3 min anal-
ysis is that the amount of sample required is fully com-
patible with future applications to real samples analysis, 
and is optimized respect to nanoMIP SPR using larger 
sample volumes (0.8–5 ml) [68, 69]. The rapid adsorption 
dynamic for the analyte was compatible with real time 
monitoring and can be related to the higher accessibility 
of the binding cavities in the nanomaterial [62, 70] and to 
its homogeneity, in comparison with macroMIPs and in 
accordance with other nanoMIPs [71–73].
Study of the response of the MIP NP SPR sensor 
to Hepcidin‑25
The MIP NP SPR sensor response to Hepcidin-25 was 
studied. Hepcidin-25 was diluted in HBS and injected in 
a range of concentrations from picomolar to nanomolar 
to determine the sensitivity of the method. Hepcidin-25 
produced a response in the range 7.2–720  pM as indi-
cated in Fig. 5a, while higher concentrations gave a con-
stant response due to the saturation of the sensor. Data 
of Fig.  5 are mediated out of five different set of meas-
urements. The Limit of Detection (LOD) of the sensor 
for Hepcidin-25 was calculated as three times the stand-
ard deviation of the baseline reflectivity (see [73]) and 
resulted 5 pM.
The calibration curve for Hepcidin-25 was built by 
plotting the logarithm of the concentration vs. the Δ 
Response Units (ΔRU), as shown in Fig.  5b. The lin-
ear fit equation for the calibration curve was f(x) = 6.07 
ln(x) + 7.03 and the R2 was 0.98.
The determination of Hepcidin-25 with the MIP NP 
SPR was at the picomolar level, with evident gain in sen-
sitivity over an anti-Hepcidin-25 based SPR that was 
reported linear in the range 0.36–360 nM [74]. The low 
picomolar determination of Hepcidin-25 was reported so 
far with the sandwich immunoassays and in HPC-ICP-
MS, respectively with LOD 35 and 140  pM [75] and in 
recent results with LC-HRMS where the reported LOD 
was 100  pM [47]. So far our MIP NP based sensor dis-
played the highest sensitivity for Hepcidin-25, while 
retaining the shortest analysis time.
The selectivity of the MIP NP SPR sensor
To evaluate the selectivity of the sensor the response to the 
truncated form of the hormone, Hepcidin-20, was studied. 
The results reported in Fig. 6 showed lack in proportional-
ity between the increasing concentrations of Hepcidin-20 
injected (7.2–720 pM) and the observed signal (ΔRU) of 
the sensor. This accounts for the selectivity of the sensor 
Fig. 4 The injection time of Hepcidin-25 into the MIP NP SPR sensor. Different injection volumes of Hepcidin-25 were tested (from 30 to 300 µl) at a 
constant flow rate of 30 µl/min allowing the contact time between the ligand and the analyte to vary from 1 to 10 min (a 1 min, b 3 min, c 5 min,  
d 10 min). An injection volume of 90 µl (3 min) b was chosen for all the experiments
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for Hepcidin-25 but not Hepcidin-20, indicating once 
more that the MIP NPs target specifically the N terminus 
of Hepcidin-25. However a significant increase in RU was 
observed for high loads of Hepcidin-20 (i.e. 720 pM). This 
could find explanation by the assumption that at concen-
trations of analyte close to the saturation limit of the sens-
ing surface, unspecific interactions at the surface prevail. 
Such interactions, which cannot be previewed with the 
ITC experiments, warn us about the limits of operation 
of the MIP NP SPR sensor and indicate the necessity to 
reduce the unspecific binding prior to apply the sensor to 
the measurement of real samples.
Stability and reproducibility of the MIP NP SPR
In order to ensure a constancy of the binding properties 
of the SPR surface, the sensor surface was regenerated 
prior to perform each set of analysis. This was obtained 
by a fresh immobilization of biotinylated-MIP NPs onto 
the chip surface, the level of regeneration was controlled 
by monitoring the change in the refractive angle. In these 
working conditions, the reproducibility of the sensor 
response, studied over five regeneration cycles, was per-
formed by injecting a 7.2  pM solution of Hepcidin-25 
and the calculated coefficient of variation was CV = 5.36 
(corresponding to a CV % of 18 %).
Fig. 5 MIP NP SPR sensor response to Hepcidin-25. a Hepcidin-25 was injected at 7.2 pM (light blue curve), 14 pM (green curve), 72 pM (violet curve), 
140 pM (orange curve) and 720 pM (red curve). The signal was recorded over timed and plotted as response units (RU). The sensorgrams of the 
MIP-NP-sensor response for Hepcidin-25 are shown in the inset. b Hepcidin-25 showed a log-linear response in the range 7.2–720 pM. A calibration 
curve was thus built for Hepcidin-25 by plotting the logarithm of the concentration vs ΔRU (Response Unit): the linear fit equation was f(x) = 6.07 
ln(x) + 7.03 and the R2 was 0.98
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The sensor performance in serum samples
The analytical determination of Hepcidin-25 in the serum 
samples is the final purpose of our attempts to exploit 
frontier research in nanotechnology to the development 
of analytical methods. The MIP NP SPR sensor was put 
at test for the quantification of Hepcidin-25 directly in 
serum samples spiked with a final concentration of 14 or 
50 pM of the hormone. It was recently reported about a 
SPR sensor based on a MIP nanosurface where the meas-
urement of testosterone from serum samples was heav-
ily hampered by the complexity of serum components, so 
that unspecific binding resulted in out of scale changes in 
the refractive index [73]. To avoid the same problem, we 
set up a protocol for the treatment of the serum samples, 
prior to the SPR analysis. Sera, spiked with Hepcidin-25 
and diluted 250 times were filtrated on ultrafiltration 
membranes previously treated to reduce adsorption 
[76] (details in Additional file 5) and injected in the MIP 
NP SPR sensor. The Hepcidin-25 concentration in the 
serum samples was 14 and 50  pM. The measured con-
tents in Hepcidin-25 were 15 ± 6 pM and 120 ± 67 pM. 
The measurements showed high standard deviations and 
scarce agreement between the known and measured con-
centrations, accounting for the unspecific adsorption of 
serum components at the chip surface. It can be hypoth-
esized that the determination of Hepcidin-25 in serum 
samples shall need a calibration curve prepared in serum 
mimic. Alternatively the passivation of the chip surface 
after MIP NP derivatization shall be performed. Despite 
the performance of the MIP NP recognition element, to 
date, sera were still not quantifiable with our sensor.
Conclusions
The present research demonstrated the possibility to 
produce polymeric NPs of 20–50  nm size, with high 
affinity and selectivity for Hepcidin-25 through the MIP 
technology. The MIP NPs were integrated into a SPR sen-
sor and were proven to determine Hepcidin-25 in the 
picomolar range (7.2–720  pM) while discriminating the 
non regulative Hepcidin-20.
Our results stress the key role of MIP nanomaterials, 
in particular of the nano-sized MIP NPs, on the perfor-
mance of the SPR sensing. Micro-MIP based SPR were 
reported to reach at best nanomolar sensitivities when 
particular polymeric properties were exploited, such as 
swelling, so to amply the shift in the reflectivity angle 
upon binding [77], or when the MIP polymers were 
admixed to conductive metallic nano-objects (Au NPs or 
Au nanostars), so to form discrete conductive compos-
ites to propagate the plasmonic wave [22, 78, 79]. How-
ever, the development of methods to growth controlled 
MIP nanofilms or NPs yielded to the achievement of SPR 
detection sensitivities in the picomolar range [69] and 
the formation of fractal superporous architectures in the 
nanoMIP allowed to reach the femtomolar level of detec-
tion (LOD 3.5 fM) [73]. Here we demonstrated the pM 
detection level gained by the use of fully polymeric MIP 
nanosized recognition elements in SPR. These significant 
sensitivities can be explained by: (1) the formation of 
high-affinity cavities in the material during the imprint-
ing process and (2) the “almost” molecular dimensions 
of the MIP NPs allows these recognition elements to be 
placed in close proximity to the sensor surface and to 
offer easy access to the analyte.
The further key outcome of the present work is the use-
ful indication for the progresses of the methodologies 
for the quantitative determination of Hepcidin-25. The 
MIP NPs demonstrated stability, high affinity and selec-
tivity, thus the MIP NPs appear to be an ideal recogni-
tion element for Hepcidin-25 dosage. Integrated into the 
MIP NP SPR proved an effective mean for the fast detec-
tion of Hepcidin-25 (3 min) in a range of concentrations 
(picomolar) that is actually reached only with much more 
labour intensive and time-requiring approaches.
Moreover, the possibility offered by the MIP NP to 
lower down of about 1000 times the LOD for Hepci-
din-25 detection, respect the actual measurements, can 
be of significant impact in medicine, allowing a clinical 
evaluation of the Hepcidin-25 levels in previously non 
measurable conditions.
On a broader perspective, the versatility of the imprint-
ing process and the results here achieved suggest a wide-
spread scenario of applications for the MIP NPs, such 
as their general employment as recognition element, or 
plastic antibodies, in analytical methods for a global tar-
geting of actually undetected peptides and proteins that 
have key roles in biological processes and pathogenesis 
but for many reasons elude the existing dosages.
Fig. 6 MIP NP SPR sensor response to Hepcidin-20. Hepcidin-20 
was injected at increasing concentration in the sensor. The response 
to Hepcidin-20 was not proportional to the injected concentration, 
indicating the selectivity of the sensor
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Methods
Acrylamide (Aam), Methacrylic acid (MAA), N-t-but-
ylacrylamide (TBAm), N,N′-methylenebisacrylamide 
(BIS), Diethylaminoethylacrylate (DEAEm), N,N,N′,N′-
tetramethylethylenediamine (TEMED), ammo-
nium persulfate (APS), sodium dodecyl sulfate (SDS), 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), sodium dihydrogen phosphate, sodium 
monohydrogen phosphate, sodium chloride, ethylen-
diaminetetraacetic acid (EDTA), Tween-20, acetic anhy-
dride, dichloromethane (DCM), dimethylformamide 
(DMF), piperidin, di-tert-butyl dicarbonate, hydra-
zine, triisopropylsilane (TIS), dimethylsulphoxide 
(DMSO), N,N′-Diisopropylcarbodiimide (DIPEA), O-(2-
Aminoethyl)-O′-[2-(biotinylamino)ethyl]octaethylene 
glycol (biotin-PEG amine), trifluoroacetic acid (TFA) 
were obtained from SIGMA-ALDRICH (Darmstadt, 
Germany). Amino acids (Fmoc and side chain protected), 
1-Hydroxybenzotriazole (HOBt) N,N,N′,N′-Tetramethyl-
O-(benzotriazol-1-yl)uronium tetrafluoroborate (TBTU), 
4-Benzyloxybenzyl Alcohol Resin (Wang resin) was from 
StepBio (Bologna, Italy). Acetonitrile, methanol, etha-
nol were purchased from Vetrotecnica (Padova, Italy). 
Acryloxyethyl thiocarbamoyl Rhodamine B was from 
Polysciences, Inc. (Warrington, USA) BioCap sensor was 
purchased from ICx Technologies (Oklahoma City, USA), 
synthetic Hepcidin-25 and Hepcidin-20 were from Pep-
tide International (Louisville, KY, USA). NR10 (NIDAL-
GMEGR) was from TAG Copenhagen A/S (Copenhagen, 
Denmark). Serum samples were from healthy volunteer 
donors. PBS: 20 mM phosphate buffer pH 7.4, 150 mM 
NaCl, 0.01 % Tween. HBS: 10 mM Hepes pH 7.4, 0.15 M 
NaCl, 3.4 mM EDTA, 0.05 % Tween-20.
Peptide synthesis
Peptide of sequence DTHFPI was obtained by solid phase 
peptide synthesis as C-terminal acids [80]. Nα-Fmoc-
protected amino acids (threefold excess) were coupled 
by using TBTU (threefold excess) and DIPEA (4.5-fold 
excess). All amino acids were coupled twice. After Fmoc-
deprotection with 25  % piperidine in DMF, the final 
cleavage of the peptide from the resin and the side chain 
protecting groups was performed with the mixture 
TFA/H2O/TIS 95/2.5/2.5. Peptides were purified by 
reverse-phase HPLC (RP-HPLC) and characterized by 
SELDI-MS.
Synthesis of nanoparticles (NPs)
Acrylamide (Aam), Methacrylic acid (MAA) and N-t-
butylacrylamide (TBAm) were added at 8, 8 and 4  % 
(w/v) respectively, N, N′-methylenebisacrylamide (BIS) 
was added at 80  % (w/v) and SDS was added at 0.02  % 
(w/v). Monomers and SDS were mixed in 10 ml of H2O 
to reach a total monomer concentration of 0.2 and 
0.5 % (w/v) (14 and 35 mM, respectively). The solutions 
were filtered with a cut-off limit of 0.2 µm. The peptide 
DTHFPI was added to the MIP-vials at the final concen-
tration of 32 and 200 µM. Vials were closed with rubber 
caps and were sonicated for 10 min. Afterwards, N2 was 
bubbled through the reaction mixture for 30  min. Fol-
lowing the addition of APS (0.04  % w/v) and TEMED 
(0.03 % w/v) the polymerization was carried out at 20 °C 
for 20 h. Nanoparticles (NPs) were suspended in 250 ml 
of 50 mM Tris and then extensively dialyzed against 3 l of 
pure water using a Vivaflow 50 system (100,000 MWCO) 
(Sartorius Stedim Italy, Firenze, Italy). Control, non-
imprinted NPs (NIP) were synthesized using the same 
protocol but in absence of the template peptide. A second 
batch of NIP (NIP-R) was synthesized with the follow-
ing composition: Aam (8  %), MAA (8  %), TBAm (2  %), 
Acryloxyethyl thiocarbamoyl Rhodamine B (2 %) and BIS 
(80 %). The yield of polymerization was calculated from 
the weight of the lyophilized NPs with respect to the total 
weight of the monomers added to the synthetic batch.
Dynamic light scattering
Size distribution and polydispersity index (PDI) were 
determined by Dynamic Light Scattering (DLS) using 
a Zetasizer Nano ZEN3600 (Malvern Instruments Ltd, 
Worcestershire, UK) equipped with a 633  nm He–Ne 
laser. Particles were dissolved in PBS to a final concentra-
tion of 1 mg/ml and filtered 0.22 µm. A particle refractive 
index (RI) of 1590 and an absorption value of 0.01 were 
assumed and a detection angle of 173° was used.
Static light scattering
The number average molar mass (Mn) was measured 
using 5 NP concentrations in the range 1–0.063  mg/ml 
after the instrument was calibrated with milliQ water. 
Raw data were used to build a Debye plot (KC/Rθ vs the 
particle concentration, where K is an optical constant, C 
is the particle concentration and Rθ is the sample Ray-
leigh ratio) whose linear fit intercept is 1/Mn. The molec-
ular weight was estimated assuming a particle refractive 
index increment (dn/dC) of 0.17  ml/g and a spherical 
particle shape (Rg = 0.740 Rh) [81, 82]. The RI, viscosity, 
absorption values and the Rayleigh ratio were provided 
by the Zetasizer v.6.32 software (Malvern instruments 
Ltd, Worcestershire, UK) while the refractive index incre-
ment (dn/dC) was found in the American Polymer Stand-
ards Corporation.
Zeta potential
The zeta potential was measured by dissolving NPs in 
10  mM NaCl to a final concentration of 3  mg/ml and 
the measurements were performed using the universal 
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dip cell (ZEN1002). The zeta potential was estimated by 
applying the Smoluchowski model (for small particles in 
aqueous media) and by using the water viscosity and RI 
values (RI = 1330 and viscosity = 0.8872 cP).
AFM
For the AFM analysis NPs dissolved in water–ethanol 
solution at 1 mg/ml and diluted 10 and 100 times in iso-
propyl alcohol, then a drop of liquid was deposited onto 
clean silicon wafer and vacuum dried. The AFM images 
were acquired with a Unisolver P47 Scanning Probe 
Microscope from NT-MDT. Analyses were performed in 
semi-contact mode with a NSG10 silicon tip with a nom-
inal radius of less than 10 nm (force constant is ~20 N/m 
and resonant frequency is ~300  kHz).  Sample were ini-
tially scanned over an area of 10 ×  10  µm2 in order to 
find a suitable place (clean from “dust” or big parti-
cles) for a more detailed analysis and then images were 
acquired with 1 × 1 µm2 scans or less.
SEM
The secondary electron images of the NPs were obtained 
with a FE-SEM JEOL 7401, at 1–3 keV beam energies and 
10 µA of emitted current.
For the SEM analyses NPs dissolved in water–ethanol 
solution at 1 mg/ml; the dispersion was further diluted 10 
and 100 times in deionised MilliQ water; the dispersion 
was deposited onto a silicon wafer substrate and vacuum 
dried to evaporate the water. Part of the water crystallises 
around the particles as visible in the SEM micrographs.
The surface of mono-crystalline silicon wafer is smooth 
at near atomic level so it provides a good morphological 
contrast with the NPs. The contrast between the NPs and 
the silicon flat was enhanced by applying a 12° tilt of the 
sample holder. The nano-particles appear brighter than 
the flat substrate.
The low energy impinging electron beam did not cause 
any noticeable charging effect nor drift in the particles 
position.
Isothermal titration calorimetry (ITC)
A Nano ITC Standard Volume (TA Instruments, Newcas-
tle, USA) with a fixed gold cell was used to perform exper-
iments. All the bindings were performed at physiological 
pH, in view of the final scope of the work which was to 
use the MIP NPs for the measurements of hepcidin-25 in 
serum samples. NPs (1.2  µM) and peptide (4  µM) were 
dissolved in PBS, sonicated for 10 min and then degassed 
under vacuum for 15 min prior to be loaded in the cal-
orimeter. The reference cell was filled with 200  μl of 
degassed deionized water, the sample cell was filled with 
an equal volume of NPs (MIP/NIP) while 50 μl of peptide 
solution was loaded in the syringe. Each ITC experiment 
consisted of 12 injections of 4 μl at an interval of 300 s 
from each other with a stirring speed of 250 rpm. Experi-
ments were performed at 25  °C. Data were fitted with 
independent sites model using the Nano Analyze Soft-
ware v. 2.3.6 (TA Instruments, New Castle, DE, USA) 
and the dissociation constant (Kd), the reaction stoichi-
ometry (n), the enthalpy, entropy and free energy vari-
ation (ΔH, ΔS and ΔG) were calculated. The equation 
selected was Independent site model equation: A = Mol 
Syringe, B = Mol Cell·n, C = −Ka A – Ka B − (Cell Vol-
ume/106), Bound =  (−C-sqr(C2 −  4Ka2AB))/(2Ka), Old 
Bound = Bound·(Total Cell Volume – Injection Volume)/
Total Cell Volume, y = 109·(Bound − Old Bound) dH.
NP conjugation with biotin‑PEG‑amine
NPs (1 equivalent) and TBTU coupling reagent 
(O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium 
tetrafluoroborate) (1 equivalent) were dissolved in 
DMSO. Simultaneously biotin-PEG-amine (3 equiva-
lents) was dissolved in DMSO as well and added to the 
reaction mixture. DIPEA (N,N-Diisopropylethylamine) 
(1.5 equivalents) was finally added and the pH of the 
solution was checked (DIPEA was added till the pH was 
in the range 8–9). The reaction lasted 1 h, then the mix-
ture was dialyzed against abundant water.
Characterization of biotinylated NPs
The size distribution of control and biotinylated NPs 
was evaluated by Dynamic Light Scattering (DLS). Con-
trol and biotinylated NIP-R, dissolved in water to 1 mg/
ml, were filtered 0.22  µm and loaded onto a reverse-
phase HPLC Ascentis® C18 column (250 mm × 4.6 mm) 
(Sigma-Aldrich). The separation method was: flow rate 
1 ml/min, injection loop 20 μl and detection wavelength 
560  nm. NPs were eluted using the following gradient: 
10  % B for 1  min, 10–90  % B in 20  min (A: water with 
0.1 % trifluoroacetic acid (TFA) B: acetonitrile with 0.1 % 
TFA).
Sensor chip derivatization
A BioCap chip (ICx Technologies, Oklahoma City, USA) 
was used: the BioCap surface is a carboxylated ethylene 
oxide surface with covalently immobilized NeutrAvidin™. 
Biotinylated MIPs (05 MIP32) were dissolved in HBS to 
a final concentration of 0.3 µM, sonicated for 10 min and 
centrifuged at 11,000 rpm for 5 min. The chip surface was 
derivatized with MIPs using an off-instrument protocol: 
100 μl of supernatant were placed onto the chip surface 
and incubated for 2  h at room temperature under mild 
shaking. The chip surface was washed three times with 
100 μl of HBS prior to be re-inserted in the instrument 
and was then let under flow (30 µl/min) until equilibra-
tion of the baseline.
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SPR measurements
Measurements were performed on a SensiQ Pioneer fully 
automated, three channel, surface plasmon resonance-
based biosensing system (Icx Technologies, Oklahoma 
City, USA). The optical system is based on the SPREETA 
sensor developed by Texas Instruments, Inc. The sensor 
is designed in a Kretschmann [83] configuration where 
monochromatic light (870 nm) is reflected from the sens-
ing surface over a range of incident angles thereby causing 
an angle-dependent reflectance minimum that is detected 
by the photodiode array. The SPR chip is a glass chip coated 
with a semitransparent 50 nm gold film, the optical reflec-
tion guide is composed of a glass prism with high quality 
optical surfaces that enable light from a light emitting diode 
(LED) to undergo SPR and to be reflected onto a photodi-
ode array (PDA) on the same plane. Measurements were 
performed at a constant flow rate of 30  µl/min. Different 
injection volumes were tested (from 30 to 300  µl) allow-
ing the contact time between the ligand and the analyte to 
vary from 1 to 10 min. An injection volume of 90 µl was 
chosen for all the experiments. Hepcidin-25 was diluted in 
HBS and injected at different picomolar and nanomolar to 
determine the linearity range. Afterwards Hepcidin-25 and 
Hepcidin-20 were compared in their linearity range.
Serum samples analysis
Hepcidin-25-spiked serum samples and negative con-
trols were filtered with 10  K molecular cut-off to elimi-
nate high molecular weight contaminants and the 
flow-through was injected. 10  K cellulose centrifugal 
filter devices (Amicon® Ultra-0.5, Millipore Corpora-
tion) were treated with the following protocol for the 
handling of highly hydrophobic proteins: filters were 
incubated overnight with 0.5  % Tween-20, rinsed with 
water, loaded with 400 µl of 100 mM glycine and centri-
fuged at 12,000  rpm for 10  min. Filters were incubated 
2 h with 0.5 % Tween-20 again, loaded twice with 400 µl 
of deionized water and centrifuged. Serum samples were 
diluted 1:10 (v/v) with HBS and Hepcidin-25 was spiked 
to nanomolar concentrations. Samples were filtered with 
the previously treated devices (12,000  rpm for 10  min) 
and the flow-through was diluted 1:25 (v/v) with HBS 
again. The spiked Hepcidin-25 was therefore in the range 
15–200 pM.
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